Tata Capital Growth Fund is set to invest Rs 225 crore (USD 30 million) to buy 0.85 per cent minority stake in Biocon Biologics, which is the subsidiary of Biocon Limited, handling the company’s biosimilar business.

The consolidated net sales reported in Q1FY21 came in at Rs 91,238 crore, which declined by 43.8 per cent YoY from Rs 1,62,353 crore in Q1FY20. 

India’s largest public sector bank, State Bank of India will report its Q1FY21 result today. Here is a sneak-peek to the stock’s technical position.

The company generates nearly 48 per cent revenue from the consumer electronics segment, which mainly comprises of LED TVs. During Q4FY20, the company added three new customers for this business including Toshiba. The company is in a process to enhance LED TV capacity to 4.4 million units in FY21 from 3.6 million currently.

Exactly a year ago, Prudential Global Investment Managers (PGIM) had completed the purchase of its previous 50 per cent held joint venture with DHFL.

Despite markets losing close to a per cent on the Futures & Options (F&O) expiry day, the July series ended with gains of almost 868 points or 8.47 per cent. Early trends in SGX Nifty suggests that the first trading session of the August F&O series is likely to begin with optimism. At 7:45 AM, SGX Nifty is trading with gains of 0.57 per cent at 11,147.50 level.

A weekly close below 11,058 could lead to 10,800 levels. However, a close above Thursday's high would be a positive sign. Stocks in news: Wipro, Kesoram Industries.

The consolidated net sales reported in Q1FY21 came in at Rs 1,980 crore, which declined by 12.9 per cent YoY from Rs 2,273.3 crore in Q1FY20. 

Mutual funds have tentatively changed the cut off timings. Read on to find out more about it.

The consolidated net sales reported in Q1FY21 came in at Rs 2,056 crore, which increased by 1.68 per cent YoY from Rs 2,022 crore in Q1FY20.